Access To Advanced Health Institute

Seattle, WA Doing business as Aahi

UEI
EMQ1ANLATYS6
CAGE
06UF1
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
CoLabs, 222 5th Ave N, Seattle, WA 98109, USA
Website
aahi.org
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$438,446
FY2025 -$194,968
FY2024 $7,857,491
FY2023 $5,875,992

Contract vehicles

No active vehicles.

2 expired vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Fred Hutchinson Cancer Center AAHI will create, validate, and provide R&D-grade HIV-Env immunogenexpressing self-amplifying RNAs (saRNAs) complexed with the nanostructured lipid carrier… U19AI174242 $22,034
Texas Biomedical Research Institute Advancing Innovative Next Generation Heterologous Vaccines Against Tuberculosis. R61AI169026 $213,944
Fred Hutchinson Cancer Center Specific Aim #1: Manufacture and release an engineering grade 426c.Mod.Core-C4b saRNA/NLC vaccine candidate. a. Prepare & review draft master production records… U19AI174242 $1,393,751
Fred Hutchinson Cancer Center AAHI will create, validate, and provide R&D-grade HIV-Env immunogenexpressing self-amplifying RNAs (saRNAs) complexed with the nanostructured lipid carrier… U19AI174242 $113,554
University Of Washington University of Washington/Fred Hutch Center for AIDS Research. P30AI027757 $39,570

Similar vendors

About the company

Access To Advanced Health Institute (AAHI), doing business as Aahi, Idri, and Infectious Disease Research Institute, is a nonprofit biotech research institute located in Seattle, Washington. AAHI combines academic research with biotech product development capabilities to combat infectious diseases. Through federal contracts, AAHI conducts research and development of vaccine candidates for biodefense, antimicrobial resistant infections, emerging infectious diseases, and respiratory pathogens. Major federal funding agencies include NIH, ASPR, Army, and DHA. As a prime contractor, AAHI has provided investigational vaccine products, performed research on genetic adjuvants, and developed multivalent vaccines. As a subcontractor, AAHI has produced HIV and gonococcal vaccine candidates.

Through federal grants, AAHI conducts applied research on vaccine adjuvants and RNA vaccine technology. As a prime grantee, AAHI investigated genetic adjuvants to enhance immune response for RNA vaccines. As a subgrantee, AAHI advanced HIV, TB, and influenza vaccine candidates, performed preclinical testing, and conducted efficacy studies. Major federal funding agencies include DHA, NIH, and CDC. Prime grant partners include universities, cancer centers, and research institutes.

Quick answers

Is Access To Advanced Health Institute registered in SAM.gov?

Yes. Access To Advanced Health Institute's SAM.gov registration is active through September 1, 2027.

Which contract vehicles does Access To Advanced Health Institute hold?

Access To Advanced Health Institute holds a place on 2 federal contract vehicles, including IVAAA and In Vitro Antimicrobial Assessments 2011-2018.

How much has Access To Advanced Health Institute received in federal contracts?

Federal contracts obligated $13,100,069 to Access To Advanced Health Institute in fiscal years 2023 through 2027.

What is Access To Advanced Health Institute's most recent federal award?

Access To Advanced Health Institute's most recent federal contract award is BAA research area 001: development of vaccine candidates for biodefense, antimicrobial resistant (AMR) infections and… (75N93023C00018), from National Institute of Allergy and Infectious Diseases (NIH), on July 5, 2023.

On GovTribe

See Access To Advanced Health Institute's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors